Aibotai

Aiboteke is dedicated to providing high-quality, market-driven products and services—professional, reliable, and tailored to meet the needs of diverse fields such as basic research, translational research, and precision medicine in cutting-edge biopharmaceuticals.

Bang'er Orthopedics

Bang'er Orthopedic Hospital Group Co., Ltd. is a nationally recognized, professional hospital investor and operator that, after nearly 20 years of dedicated development, has steadily grown into a leading orthopedic chain brand in China.

Dianjing Bio

Dima Biotech

Dimai Biotech is a national-level high-tech enterprise dedicated to the research, development, manufacturing, sales, and service of in vitro diagnostic medical devices and reagents.

Douyu

Douyu TV is a bullet-comment-style live-streaming and video-sharing platform that provides users with live video broadcasts and event coverage.

Voda Semiconductor

Voda Semiconductor is a company dedicated to the research and development of wireless charging and wired fast-charging technologies.

Fuchihigh Tech

Founded in November 1999, Fuchi High-Tech is a leading Chinese and globally advanced manufacturer specializing in professional Metal Injection Molding (MIM) and Ceramic Injection Molding (CIM) products.

Finnova Automation

Finnova Automation is a smart factory service provider dedicated to delivering comprehensive solutions for the high-end intelligent manufacturing industry.

Arctic Light Venture Capital

Founded in 2005 by Mr. Deng Feng, Northern Light Venture Capital has long been dedicated to investing in promising early-stage, technology-driven companies, emphasizing the principles of "team, market, and innovation." The firm grows alongside its portfolio companies, managing total assets worth 30 billion yuan.

Bencao Capital

Bencao Capital is a specialized fund focused on the healthcare industry, investing in areas such as new drug development, medical devices, clinical diagnostics, and healthcare services.

Mint Angel Fund

The Mint Angel Fund is an early-stage venture capital fund focused on investing in and incubating technology-driven healthcare startups. With the mission of "building a bridge between R&D and commercialization, accelerating innovation and entrepreneurship in healthcare," the fund actively identifies and invests in entrepreneurial teams that possess cutting-edge platform technologies.

Boxin Capital

Boxin Capital focuses on equity investments and mergers & acquisitions in growth-stage and mature-stage companies poised for IPOs—sectors closely tied to China's rapid economic expansion. The firm currently manages a total fund size of nearly 9 billion yuan.

Chen De Capital

ChenDe Capital is an investment firm specializing in the life sciences and medical technology sectors, managing multiple USD-denominated and RMB-denominated funds with a total scale exceeding 4 billion RMB.

Chen Yi Investment

At the start of 2021, Chenyi Investment successfully closed fundraising for its first RMB-denominated M&A fund, reaching a total size of 6.8 billion yuan. Focusing on industries driven by structural transformation and innovative growth, Chenyi Investment is committed to long-term partnerships with companies that demonstrate strong growth potential, helping them thrive while continuously delivering value to investors and society.

Chi Xing Venture Capital

Established in 2016, Chixing Venture Capital was jointly launched by iFlytek and Yuanhe Mother Fund. Focused on intelligent interaction, the firm specializes in investing in early-stage projects within the AI industry. Its first-phase angel investment fund totals RMB 200 million, while the second-phase growth fund is set at RMB 1 billion.

Hai Purunsi

Haipe Runds is a high-tech enterprise dedicated to the research and development, large-scale production, and sales of organic light-emitting diode (OLED) materials.

Han Tianxia

Han Tianxia was founded in 2015 and primarily focuses on the research and development of RF filters, as well as related RF chips and components.

Hengsheng Graphite

Hengsheng Graphite is a national-level high-tech enterprise dedicated to the research and development, production, and processing of isostatically pressed graphite products.

Hualan Biological Vaccine

Hualan Biological Vaccine is an innovative biopharmaceutical company integrating vaccine research and development with manufacturing. Focused on addressing the needs of infectious disease prevention and control, the company prioritizes the development of novel vaccine products—particularly those for human use that are in high demand or urgently needed for disease prevention and public health protection.

Hua Mai Tai Ke

Huamaiteke was founded in 2011 and has developed two core products: the Abdominal Aortic Covered Stent Graft System and the Thoracic Aortic Covered Stent Graft System. These innovative solutions feature globally advanced technology tailored to the unique characteristics of aortic dissection and aortic aneurysm conditions prevalent among Chinese patients.

Yellow Swan

Jingyu Group

Jingyu Group specializes in the research, development, and manufacturing of pharmaceutical and chemical-related products. It is a corporate group whose growth strategy spans from specialty APIs to challenging generic drugs and innovative formulations.

Jiepei

Jiepei is a platform-based high-tech enterprise dedicated to building an ECMS-enabled super factory for collaborative manufacturing in the electronics industry. Its business spans multiple areas, including PCBs, PCBA, components, 3D printing, injection molding, sheet metal fabrication, mold making, CNC machining, and integrated delivery solutions.

Chuanliu Capital

Chuanliu Investment was established in 2016 and focuses on investments in the fields of new materials and chemical technology. Leveraging a combination of expert investment expertise, industry resources, and insightful market knowledge, we aim to identify high-growth investment opportunities. By driving fundamental growth through technological innovation, industrial upgrades, and enhanced societal value, we strive to deliver strong investment returns.

Dacheng Capital

Junlebao

Founded in 1995, Junlebao Dairy Group has established 21 production facilities and 17 state-of-the-art, large-scale dairy farms across regions such as Hebei, Henan, Jiangsu, and Jilin. The company’s business spans a wide range of product categories, including infant formula, yogurt, refrigerated fresh milk, room-temperature liquid milk, as well as dairy farming and forage industries. Junlebao has created a comprehensive operational structure that covers the entire dairy industry chain, fostering synergistic development across both upstream and downstream sectors, all while delivering nutritious, healthy, and safe dairy products to consumers.

Cayoude Bio

Cayudi Biotechnology (Beijing) Co., Ltd. is a domestically produced, pioneering high-tech innovation enterprise that has been deeply rooted in the molecular diagnostics field for over a decade, with particular expertise in rapid nucleic acid detection technologies for pathogenic microorganisms.

Dattai Capital

Founded in 2010, Dattai Capital is a third-party, professional investment firm specializing in early-stage and growth-phase private equity investments. It currently manages multiple RMB- and USD-denominated funds.

Daotong Investment

Daotong Investment focuses on early-stage investments and industrial M&A in the greater healthcare sector, with a particular emphasis on medical services and innovative healthcare technologies.

DeLian Capital

Founded in 2011, Delian Capital focuses on technology-driven projects in sectors such as hard tech, cutting-edge technologies, and innovative healthcare.

DeTong Capital

DeTong Capital is a leading domestic private equity fund management company, specializing in investments across the TMT, consumer goods, healthcare, and advanced manufacturing sectors. Currently, the firm manages assets nearing 20 billion RMB.

Dingyi Investment

Founded in 2015, Dingyi Investment primarily focuses on investing in various distressed assets that emerge during China’s economic restructuring and industrial transformation and upgrading—opportunities that often arise as traditional industries evolve. The firm manages a total fund size nearing 10 billion RMB.

Fangguang Capital

Founded in 2012, Fangguang Capital specializes in identifying and nurturing international companies across the IT industry's upstream and downstream sectors. The firm primarily invests in technology-driven enterprises experiencing rapid growth, many of which have since become industry leaders while maintaining their momentum for sustained high-speed expansion.

Share the investment

Founded in 2007, Share Investment focuses on early-to-mid-stage investments across three key sectors: healthcare, consumer innovation, and cutting-edge technology. Currently, the firm manages assets exceeding RMB 8 billion.

Hillhouse Capital

Hillhouse Capital Group is a company focused on long-term, structurally driven value investing, with investments spanning sectors such as TMT, healthcare, consumer goods, and business services. It covers the entire spectrum of equity investments—ranging from early-stage seed funding and venture capital to private equity, public-listed company investments, and even mergers & acquisitions.

Gobi Ventures

Gobi Partners was founded in 2002 and is a leading venture capital firm in China, as well as the first domestically rooted VC firm to expand into Southeast Asia. With a globally oriented investment perspective, Gobi Partners manages multiple USD- and RMB-denominated funds.

National Innovation to Glory

Guochuang Zihui is positioned as a private equity investment fund focused on the real economy, with primary investments concentrated in four key sectors: high-end manufacturing, IoT communications, consumer-upgrade industries, and green/environmental protection initiatives. The fund targets high-value-added startups and growing enterprises within the industrial chain, primarily operating in the economically vibrant Yangtze River Delta region.

Guo Ke Jiahe

Founded in 2011, Guoke Jiahe Fund manages assets totaling hundreds of billions of RMB. The fund focuses on high-growth, high-tech industries with significant barriers to entry, including TMT and life sciences—emerging sectors where it strategically invests in areas such as IoT-driven intelligent manufacturing, semiconductors and IT, big data, cloud computing, artificial intelligence, fintech, and biopharmaceuticals.

Kunling PharmaClinChoice

Kunling PharmaClinChoice is a clinical CRO dedicated to providing high-quality, one-stop services for biopharmaceutical and medical device clients. Its services encompass project management, clinical operations, biostatistics, data management, regulatory affairs, medical affairs, and pharmacovigilance.

Housheng Investment